| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1146 | 2020 |
| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 964 | 2021 |
| SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function ES Winkler, AL Bailey, NM Kafai, S Nair, BT McCune, J Yu, JM Fox, ... Nature immunology 21 (11), 1327-1335, 2020 | 931 | 2020 |
| Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ... Nature 591 (7849), 293-299, 2021 | 682 | 2021 |
| A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ... Cell 183 (1), 169-184. e13, 2020 | 564 | 2020 |
| A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies AO Hassan, JB Case, ES Winkler, LB Thackray, NM Kafai, AL Bailey, ... Cell 182 (3), 744-753. e4, 2020 | 558 | 2020 |
| Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein N Suryadevara, S Shrihari, P Gilchuk, LA VanBlargan, E Binshtein, ... Cell 184 (9), 2316-2331. e15, 2021 | 412 | 2021 |
| Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, ... Cell 184 (7), 1804-1820. e16, 2021 | 359 | 2021 |
| In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains RE Chen, ES Winkler, JB Case, ID Aziati, TL Bricker, A Joshi, TL Darling, ... Nature 596 (7870), 103-108, 2021 | 232 | 2021 |
| Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice JB Case, PW Rothlauf, RE Chen, NM Kafai, JM Fox, BK Smith, S Shrihari, ... Cell host & microbe 28 (3), 465-474. e4, 2020 | 203 | 2020 |
| A potently neutralizing antibody protects mice against SARS-CoV-2 infection WB Alsoussi, JS Turner, JB Case, H Zhao, AJ Schmitz, JQ Zhou, RE Chen, ... The Journal of Immunology 205 (4), 915-922, 2020 | 195 | 2020 |
| SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis AL Bailey, O Dmytrenko, L Greenberg, AL Bredemeyer, P Ma, J Liu, ... Basic to Translational Science 6 (4), 331-345, 2021 | 185 | 2021 |
| The intestinal microbiome restricts alphavirus infection and dissemination through a bile acid-type I IFN signaling axis ES Winkler, S Shrihari, BL Hykes, SA Handley, PS Andhey, YJS Huang, ... Cell 182 (4), 901-918. e18, 2020 | 145 | 2020 |
| Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets HL Dugan, CT Stamper, L Li, S Changrob, NW Asby, PJ Halfmann, ... Immunity 54 (6), 1290-1303. e7, 2021 | 134 | 2021 |
| Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation TC Liu, JT Kern, U Jain, NM Sonnek, S Xiong, KF Simpson, ... Cell host & microbe 29 (6), 988-1001. e6, 2021 | 121 | 2021 |
| A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope LA VanBlargan, LJ Adams, Z Liu, RE Chen, P Gilchuk, S Raju, BK Smith, ... Immunity 54 (10), 2399-2416. e6, 2021 | 101 | 2021 |
| Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals EC Chen, P Gilchuk, SJ Zost, N Suryadevara, ES Winkler, CR Cabel, ... Cell Reports 36 (8), 2021 | 88 | 2021 |
| A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection JL Slon-Campos, W Dejnirattisai, BW Jagger, C López-Camacho, ... Nature immunology 20 (10), 1291-1298, 2019 | 88 | 2019 |
| SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies M Diamond, R Chen, X Xie, J Case, X Zhang, L VanBlargan, Y Liu, J Liu, ... Research square, rs. 3. rs-228079, 2021 | 86 | 2021 |
| Expression of the Mxra8 receptor promotes alphavirus infection and pathogenesis in mice and Drosophila R Zhang, JT Earnest, AS Kim, ES Winkler, P Desai, LJ Adams, G Hu, ... Cell reports 28 (10), 2647-2658. e5, 2019 | 81 | 2019 |
